Publication | Closed Access

Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7–expressing Metastatic Castration-resistant Prostate Cancer

UrologyMedicineHormonal ReceptorPharmacologyResponse—splice VariantPharmacotherapyRandomized TrialProstatic DiseaseOncologyGaleterone Versus EnzalutamideEndocrine-related Cancer